|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/21/24 X4 Pharmaceuticals, Inc. 10-K 12/31/23 93:9.5M Workiva Inc Wde… FA01/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.35M
2: EX-10.37 Material Contract HTML 33K
3: EX-23.1 Consent of Expert or Counsel HTML 27K
7: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 49K
Awarded Compensation
4: EX-31.1 Certification -- §302 - SOA'02 HTML 31K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 31K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 28K
13: R1 Cover HTML 95K
14: R2 Audit Information HTML 32K
15: R3 Consolidated Balance Sheets HTML 124K
16: R4 Consolidated Balance Sheets (Parenthetical) HTML 37K
17: R5 Consolidated Statements of Operations and HTML 104K
Comprehensive Loss
18: R6 Consolidated Statements of Convertible Preferred HTML 117K
Stock, Redeemable Common Stock and Stockholders'
Equity (Deficit)
19: R7 Consolidated Statements of Cash Flows HTML 120K
20: R8 Nature of the Business and Basis of Presentation HTML 37K
21: R9 Summary of Significant Accounting Policies HTML 88K
22: R10 License, Collaboration, and Funding Agreements HTML 47K
23: R11 Fair Value of Financial Assets and Liabilities HTML 129K
24: R12 Property and Equipment, Net HTML 40K
25: R13 Accrued Expenses HTML 37K
26: R14 Long-Term Debt HTML 57K
27: R15 Leases HTML 56K
28: R16 Commitment and Contingencies HTML 33K
29: R17 Preferred and Common Stock Warrants HTML 81K
30: R18 Common Stock, Redeemable Common Stock and HTML 48K
Convertible Preferred Stock (converted to Common
Stock)
31: R19 Stock-Based Compensation HTML 87K
32: R20 Income Taxes HTML 89K
33: R21 Net Loss per Share HTML 52K
34: R22 Loss on Transfer of Nonfinancial Assets HTML 31K
35: R23 Summary of Significant Accounting Policies HTML 117K
(Policies)
36: R24 Summary of Significant Accounting Policies HTML 55K
(Tables)
37: R25 Fair Value of Financial Assets and Liabilities HTML 137K
(Tables)
38: R26 Property and Equipment, Net (Tables) HTML 39K
39: R27 Accrued Expenses (Tables) HTML 37K
40: R28 Long-Term Debt (Tables) HTML 52K
41: R29 Leases (Tables) HTML 55K
42: R30 Preferred and Common Stock Warrants (Tables) HTML 78K
43: R31 Stock-Based Compensation (Tables) HTML 75K
44: R32 Income Taxes (Tables) HTML 88K
45: R33 Net Loss per Share (Tables) HTML 52K
46: R34 Nature of the Business and Basis of Presentation HTML 56K
(Details)
47: R35 Summary of Significant Accounting Policies - HTML 46K
Schedule of Restricted Cash (Details)
48: R36 Summary of Significant Accounting Policies - HTML 39K
Schedule of Cash, Cash Equivalents and Restricted
Cash (Details)
49: R37 Summary of Significant Accounting Policies - HTML 40K
Schedule of Property, Plant and Equipment
(Details)
50: R38 Summary of Significant Policies - Additional HTML 38K
Information (Details)
51: R39 License, Collaboration, and Funding Agreements - HTML 54K
Genzyme Agreement (Details)
52: R40 License, Collaboration, and Funding Agreements - HTML 39K
Georgetown Agreement (Details)
53: R41 License, Collaboration, and Funding Agreements - HTML 47K
Beth Israel Deaconess Medical Center Agreements
(Details)
54: R42 License, Collaboration, and Funding Agreements - HTML 41K
Research and Development Incentive Program
(Details)
55: R43 License, Collaboration, and Funding Agreements HTML 30K
(Details)
56: R44 Fair Value of Financial Assets and Liabilities - HTML 74K
Measured on a Recurring Basis (Details)
57: R45 Fair Value of Financial Assets and Liabilities - HTML 45K
Debt Securities Available-for-Sale (Details)
58: R46 Fair Value of Financial Assets and Liabilities - HTML 53K
Narrative (Details)
59: R47 Fair Value of Financial Assets and Liabilities HTML 55K
-Aggregate Fair Value of Warrant and Derivative
Liabilities (Details)
60: R48 Fair Value of Financial Assets and Liabilities - HTML 50K
Assumptions (Details)
61: R49 Fair Value of Financial Assets and Liabilities - HTML 42K
Goodwill Rollforward (Details)
62: R50 Property and Equipment, Net (Details) HTML 49K
63: R51 Accrued Expenses (Details) HTML 39K
64: R52 Long-Term Debt - Schedule of Long-Term Debt HTML 41K
(Details)
65: R53 Long-Term Debt - Narrative (Details) HTML 63K
66: R54 Long-Term Debt - Hercules Loan Agreements HTML 35K
(Details)
67: R55 Long-Term Debt - Future Principal Payments HTML 37K
(Details)
68: R56 Leases (Details) HTML 79K
69: R57 Leases - Schedule of Components of Lease Expense HTML 47K
(Details)
70: R58 Leases - Schedule of Maturities of Lease HTML 44K
Liabilities (Detail)
71: R59 Preferred and Common Stock Warrants - Additional HTML 84K
Information (Details)
72: R60 Preferred and Common Stock Warrants - Schedule of HTML 50K
Outstanding Warrants (Detail)
73: R61 Preferred and Common Stock Warrants - Summary of HTML 103K
Outstanding Warrants to Purchase Shares of Common
Stock (Details)
74: R62 Common Stock, Redeemable Common Stock and HTML 192K
Convertible Preferred Stock (converted to Common
Stock) - Additional Information (Details)
75: R63 Stock-Based Compensation - Additional Information HTML 94K
(Details)
76: R64 Stock-Based Compensation - Summary of Stock Option HTML 79K
Activity (Detail)
77: R65 Stock-Based Compensation - Restricted Stock Units HTML 38K
(Details)
78: R66 Stock-Based Compensation - Summary of Stock-Based HTML 42K
Compensation Expense Classification (Details)
79: R67 Stock-Based Compensation - Stock Option Valuation HTML 52K
(Details)
80: R68 Income Taxes - Schedule of Income Loss Before HTML 37K
Income Taxes (Details)
81: R69 Income Taxes - Reconciliation of Effective Income HTML 44K
Tax Rate (Details)
82: R70 Income Taxes - Deferred Income Tax Asset (Details) HTML 50K
83: R71 Income Taxes - Narrative (Details) HTML 48K
84: R72 Income Taxes - Deferred Tax Valuation Allowance HTML 33K
(Details)
85: R73 Income Taxes (Details) HTML 31K
86: R74 Net Loss per Share - Summary of Basic and Diluted HTML 65K
Net loss per Share Attributable to Common
Stockholders (Details)
87: R75 Net Loss per Share - Additional Information HTML 39K
(Details)
88: R76 Net Loss per Share - Schedule of Anti-dilutive HTML 38K
Securities Excluded from Computation of Diluted
Net Loss per Share Attributable to Common
Stockholders (Details)
90: XML IDEA XML File -- Filing Summary XML 170K
93: XML XBRL Instance -- xfor-20231231_htm XML 1.90M
89: EXCEL IDEA Workbook of Financial Report Info XLSX 146K
9: EX-101.CAL XBRL Calculations -- xfor-20231231_cal XML 190K
10: EX-101.DEF XBRL Definitions -- xfor-20231231_def XML 760K
11: EX-101.LAB XBRL Labels -- xfor-20231231_lab XML 1.70M
12: EX-101.PRE XBRL Presentations -- xfor-20231231_pre XML 1.22M
8: EX-101.SCH XBRL Schema -- xfor-20231231 XSD 212K
91: JSON XBRL Instance as JSON Data -- MetaLinks 523± 754K
92: ZIP XBRL Zipped Folder -- 0001628280-24-012578-xbrl Zip 426K
 | Download this Microsoft® Excel® .xlsx workbook |